HOME › Top Market Reports › Bone Growth Stimulator Market by Product (Device, Bone Morphogenetic Protein, PRP), Application (Spinal Fusion, Delay Union & Non-union Bone Fracture, Oral-maxillofacial), End User (Hospitals, Home Care, Academia, CROs) - Global Forecasts to 2022

Bone Growth Stimulator Market by Product (Device, Bone Morphogenetic Protein, PRP), Application (Spinal Fusion, Delay Union & Non-union Bone Fracture, Oral-maxillofacial), End User (Hospitals, Home Care, Academia, CROs) - Global Forecasts to 2022

By: marketsandmarkets.com
Publishing Date: May 2017
Report Code: MD 5234

The global bone growth stimulator market is estimated to reach USD 1.41 Billion by 2022, growing at a CAGR of 5.4% during the forecast period. The growing patient preference for non-invasive and minimally invasive surgical treatments, increasing target patient population, and procedural benefits offered by bone stimulation devices in bone fracture treatments are some key factors propelling the growth of this market.

In 2016, North America held the largest share of the market. However, the developing Asia-Pacific countries including China and India are expected to emerge as new revenue-generating regions for prominent market players during 2017-2022. The growth of this Asia-Pacific market is attributed to the presence of large geriatric population and expansion of market players in the region through capability enhancements as well as through strategic agreements and collaborations.

Orthofix International N.V. (U.S.), Medtronic plc (Ireland), and Zimmer Biomet Holdings, Inc. (U.S.) are some of the key players in the bone growth stimulator market. Over the past three years, these players have adopted product launches & enhancements, strategic acquisitions, and market expansions as their core business strategies to ensure dominance in this market. DJO Finance LLC (U.S.), Bioventus LLC (U.S.), Stryker Corporation (U.S.), DePuy Synthes (U.S.), Arthrex, Inc. (U.S.), Isto Biologics (U.S.), and Harvest Technologies Corporation (U.S.) were few other key players operating in the market.

Target Audience

Bone growth stimulation products manufacturing companies
Healthcare institutions (hospitals and outpatient clinics)
Distributors and suppliers
Research laboratories and academic institutions
Government and regulatory authorities
Non-government and other associations/organizations
Market research and consulting firms
Contract research organizations (CROS) and contract manufacturing organizations (CMOS)

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This research report categorizes the market into the following segments:

Bone Growth Stimulator Market, by Product

Bone Growth Stimulation Devices
- External Bone Growth Stimulators
  - Combined Magnetic Field (CMF) Devices
  - Capacitive Coupling (CC) Devices
  - Pulsed Electromagnetic Field (PEMF) Devices
- Implanted Bone Growth Stimulators
- Ultrasonic Bone Growth Stimulators
Bone Morphogenetic Proteins (BMP)
Platelet-rich Plasma (PRP)

Bone Growth Stimulator Market, by End User

Hospitals and Clinics
Home Care
Academic & Research Institutes and CROs

Bone Growth Stimulator Market, by Application

Spinal Fusion Surgeries
Delayed Union & Nonunion Bone Fractures
Oral and Maxillofacial Surgeries
Other Applications

Bone Growth Stimulator Market, by Region

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- RoE
Asia-Pacific
- Japan
- China
- India
- RoAPAC
Rest of the World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the bone growth stimulator market report:

Product Analysis

Product Matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company Information

Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 17)
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
                    2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Research
                    2.2.2.1 Key Data From Primary Sources
           2.2.3 Market Size Estimation Methodology
    2.3 Opportunity Indicators
                    2.3.1.1 Rapid Growth in the Geriatric Population
                    2.3.1.2 Healthcare Expenditure Patterns
                    2.3.1.3 Significant Number of Road Accidents
    2.4 Market Data Validation and Triangulation
           2.4.1 Assumptions for the Study

3 Executive Summary (Page No. - 29)

4 Premium Insights (Page No. - 34)
    4.1 Bone Growth Stimulators: Market Snapshot (2017–2022)
    4.2 Geographic Analysis: Bone Growth Stimulator Market, By Type (2017)
    4.3 Global Bone Growth Stimulator Market, By Application, 2017 vs 2022
    4.4 Global Market Size, By End User, 2017 vs 2022 (USD Million)
    4.5 Market: Geographic Growth Opportunities

5 Market Overview (Page No. - 39)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Major Market Drivers
                    5.2.1.1 Growing Patient Preference for Noninvasive and Minimally Invasive Surgical Treatments
                    5.2.1.2 Increasing Target Patient Population
                    5.2.1.3 Procedural Benefits Offered By Bone Stimulation Devices in Bone Fracture Treatment
           5.2.2 Major Market Restraints
                    5.2.2.1 Limited Medical Reimbursement for Bone Stimulation Products
                    5.2.2.2 High Treatment Costs Associated With BMP and PRP Products
           5.2.3 Major Market Opportunities
                    5.2.3.1 Emerging Markets
           5.2.4 Major Market Challenges
                    5.2.4.1 Lawsuits Filed Against Major Market Players Affecting the Brand Value
                    5.2.4.2 Side Effects Associated With BMP-Based Orthopedic Treatment

6 Industry Trends (Page No. - 44)
    6.1 Introduction
    6.2 Key Industry Trends
           6.2.1 Off-Label Use of BMP Products
           6.2.2 Increasing Use of PRP in Other Applications
    6.3 Supply Chain Analysis
    6.4 Porter’s Five Forces Analysis

7 Global Bone Growth Stimulator Market, By Product (Page No. - 47)
    7.1 Introduction
    7.2 Bone Growth Stimulation Devices
           7.2.1 External Bone Growth Stimulators
                    7.2.1.1 Pulsed Electromagnetic Field Devices
                    7.2.1.2 Capacitive Coupling Devices
                    7.2.1.3 Combined Magnetic Field Devices
           7.2.2 Implanted Bone Growth Stimulators
           7.2.3 Ultrasonic Bone Growth Stimulators
    7.3 Bone Morphogenetic Proteins
    7.4 Platelet-Rich Plasma

8 Global Bone Growth Stimulator Market, By Application (Page No. - 59)
    8.1 Introduction
    8.2 Spinal Fusion Surgeries
    8.3 Delayed Union & Nonunion Bone Fractures
    8.4 Oral and Maxillofacial Surgeries
    8.5 Other Applications

9 Global Bone Growth Stimulator Market, By End User (Page No. - 65)
    9.1 Introduction
    9.2 Hospitals & Clinics
    9.3 Home Care
    9.4 Academic & Research Institutes and CROS

10 Global Bone Growth Stimulator Market, By Region (Page No. - 70)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 U.K.
             10.3.3 France
             10.3.4 Rest of Europe
     10.4 Asia-Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 Rest of Asia-Pacific
     10.5 Rest of the World

11 Competitive Landscape (Page No. - 104)
     11.1 Introduction
     11.2 Vendor Dive Overview
             11.2.1 Vanguards
             11.2.2 Innovators
             11.2.3 Dynamic Players
             11.2.4 Emerging Players
     11.3 Competitive Benchmarking
             11.3.1 Product Offerings (For 23 Players)
             11.3.2 Business Strategy (For 23 Players)

12 Company Profiles (Page No. - 108)
     12.1 Top Market Players
             12.1.1 Orthofix International N.V.
                        12.1.1.1 Overview
                        12.1.1.2 Company Scorecard
                                     12.1.1.2.1 Product Offerings
                                     12.1.1.2.2 Business Strategy
                        12.1.1.3 Recent Developments (2013-2017)
                                     12.1.1.3.1 Product Launches, Enhancements, and Approvals
                                     12.1.1.3.2 Other Developments
             12.1.2 DJO Finance LLC
                        12.1.2.1 Overview
                        12.1.2.2 Company Scorecard
                                     12.1.2.2.1 Product Offerings
                                     12.1.2.2.2 Business Strategy
             12.1.3 Zimmer Biomet Holdings, Inc.
                        12.1.3.1 Overview
                        12.1.3.2 Company Scorecard
                                     12.1.3.2.1 Product Offerings
                                     12.1.3.2.2 Business Strategy
                        12.1.3.3 Recent Developments (2013-2017)
                                     12.1.3.3.1 Mergers & Acquisitions
             12.1.4 Bioventus LLC
                        12.1.4.1 Overview
                        12.1.4.2 Company Scorecard
                                     12.1.4.2.1 Product Offerings
                                     12.1.4.2.2 Business Strategy
                        12.1.4.3 Recent Developments (2013-2017)
                                     12.1.4.3.1 Product Launches, Showcases, Enhancements, and Recognitions
                                     12.1.4.3.2 Mergers & Acquisitions
                                     12.1.4.3.3 Expansions
                                     12.1.4.3.4 Agreements
             12.1.5 Medtronic PLC
                        12.1.5.1 Overview
                        12.1.5.2 Company Scorecard
                                     12.1.5.2.1 Product Offerings
                                     12.1.5.2.2 Business Strategy
                        12.1.5.3 Recent Developments (2013-2017)
                                     12.1.5.3.1 Product Launches, Enhancements, and Approvals
                                     12.1.5.3.2 Expansion
             12.1.6 Stryker Corporation
                        12.1.6.1 Overview
                        12.1.6.2 Company Scorecard
                                     12.1.6.2.1 Product Offerings
                                     12.1.6.2.2 Business Strategy
             12.1.7 Depuy Synthes (A Subsidiary of Johnson & Johnson)
                        12.1.7.1 Overview
                        12.1.7.2 Company Scorecard
                                     12.1.7.2.1 Product Offerings
                                     12.1.7.2.2 Business Strategy
                        12.1.7.3 Recent Developments (2013-2017)
                                     12.1.7.3.1 Product Launches, Enhancements, and Approvals
             12.1.8 Arthrex, Inc.
                        12.1.8.1 Overview
                        12.1.8.2 Company Scorecard
                                     12.1.8.2.1 Product Offerings
                                     12.1.8.2.2 Business Strategy
                        12.1.8.3 Recent Developments (2013-2017)
                                     12.1.8.3.1 Expansion
             12.1.9 Isto Biologics
                        12.1.9.1 Overview
                        12.1.9.2 Company Scorecard
                                     12.1.9.2.1 Product Offerings
                                     12.1.9.2.2 Business Strategy
                        12.1.9.3 Recent Developments (2013-2017)
                                     12.1.9.3.1 Acquisitions
             12.1.10 Harvest Technologies (A Terumo BCT Company)
                        12.1.10.1 Overview
                        12.1.10.2 Company Scorecard
                                     12.1.10.2.1 Product Offerings
                                     12.1.10.2.2 Business Strategy
     12.2 Emerging Market Players
             12.2.1 Ossatec Benelux Ltd.
                        12.2.1.1 Overview
                        12.2.1.2 Company Scorecard
                                     12.2.1.2.1 Product Offerings
                        12.2.1.3 Business Strategy
             12.2.2 Ember Therapeutics Inc.
                        12.2.2.1 Overview
                        12.2.2.2 Company Scorecard
                                     12.2.2.2.1 Product Offerings
                        12.2.2.3 Business Strategy
                        12.2.2.4 Recent Developments (2013-2017)
                                     12.2.2.4.1 Mergers & Acquisitions
             12.2.3 Regen Lab SA
                        12.2.3.1 Overview
                        12.2.3.2 Company Scorecard
                                     12.2.3.2.1 Product Offerings
                        12.2.3.3 Business Strategy
             12.2.4 Altis Biologics (Pty) Ltd.
                        12.2.4.1 Overview
                        12.2.4.2 Company Scorecard
                                     12.2.4.2.1 Product Offerings
                                     12.2.4.2.2 Business Strategy
             12.2.5 ITO Co., Ltd.
                        12.2.5.1 Overview
                        12.2.5.2 Company Scorecard
                                     12.2.5.2.1 Product Offerings
                                     12.2.5.2.2 Business Strategy

13 Appendix (Page No. - 145)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Introducing RT: Real-Time Market Intelligence
     13.4 Available Customizations
     13.5 Related Reports

List of Tables (66 Tables)

Table 1 Global Bone Growth Stimulators Market Size, By Product, 2015–2022 (USD Million)
Table 2 Global Bone Growth Stimulation Devices Market Size, By Type, 2015–2022 (USD Million)
Table 3 Global Bone Growth Stimulation Devices Market Size, By Region, 2015–2022 (USD Million)
Table 4 External Bone Growth Stimulator Market Size, By Type, 2015–2022 (USD Million)
Table 5 External Bone Growth Stimulators Market Size, By Region, 2015–2022 (USD Million)
Table 6 PEMF Devices Market Size, By Region, 2015–2022 (USD Million)
Table 7 CC Devices Market Size, By Region, 2015–2022 (USD Million)
Table 8 CMF Devices Market Size, By Region, 2015–2022 (USD Million)
Table 9 Implanted Bone Growth Stimulator Market Size, By Region, 2015–2022 (USD Million)
Table 10 Ultrasonic Bone Growth Stimulators Market Size, By Region, 2015–2022 (USD Million)
Table 11 Bone Morphogenetic Proteins Market Size, By Region, 2015–2022 (USD Million)
Table 12 Platelet-Rich Plasma Market Size, By Region, 2015–2022 (USD Million)
Table 13 Global Bone Growth Stimulator Market Size, By Application, 2015–2022 (USD Million)
Table 14 Market Size for Spinal Fusion Surgeries, By Region, 2015–2022 (USD Million)
Table 15 Market Size for Delayed Union and Nonunion Bone Fractures, By Region, 2015–2022 (USD Million)
Table 16 Market Size for Oral and Maxillofacial Surgeries, By Region, 2015–2022 (USD Million)
Table 17 Market Size for Other Applications, By Region, 2015–2022 (USD Million)
Table 18 Global Bone Growth Stimulator Market Size, By End User, 2015-2022 (USD Million)
Table 19 Global Market Size for Hospitals & Clinics, By Region, 2015-2022 (USD Million)
Table 20 Global Market Size for Home Care, By Region, 2015-2022 (USD Million)
Table 21 Global Market Size for Academic & Research Institutes and CROS, By Region, 2015-2022 (USD Million)
Table 22 Global Bone Growth Stimulator Market Size, By Region, 2015–2022 (USD Million)
Table 23 Market Size, By Country, 2015–2022 (USD Million)
Table 24 North America: Bone Growth Stimulator Market Size, By Country, 2015–2022 (USD Million)
Table 25 North America: Market Size, By Product, 2015–2022 (USD Million)
Table 26 North America: Bone Growth Stimulation Devices Market Size, By Type, 2015–2022 (USD Million)
Table 27 North America: External Bone Growth Stimulator Market Size, By Type, 2015–2022 (USD Million)
Table 28 North America: Market Size, By End User, 2015–2022 (USD Million)
Table 29 North America: Market Size, By Application, 2015–2022 (USD Million)
Table 30 U.S.: Market Size, By Product, 2015–2022 (USD Million)
Table 31 U.S.: Market Size, By Application, 2015–2022 (USD Million)
Table 32 Canada: Bone Growth Stimulator Market Size, By Product, 2015–2022 (USD Million)
Table 33 Canada: Market Size, By Application, 2015–2022 (USD Million)
Table 34 Europe: Bone Growth Stimulator Market Size, By Country, 2015–2022 (USD Million)
Table 35 Europe: Market Size, By Product, 2015–2022 (USD Million)
Table 36 Europe: Bone Growth Stimulation Devices Market Size, By Type, 2015–2022 (USD Million)
Table 37 Europe: External Bone Growth Stimulator Market Size, By Type, 2015–2022 (USD Million)
Table 38 Europe: Market Size, By End User, 2015–2022 (USD Million)
Table 39 Europe: Market Size, By Application, 2015–2022 (USD Million)
Table 40 Germany: Bone Growth Stimulator Market Size, By Product, 2015–2022 (USD Million)
Table 41 Germany: Market Size, By Application, 2015–2022 (USD Million)
Table 42 U.K.: Bone Growth Stimulator Market Size, By Product, 2015–2022 (USD Million)
Table 43 U.K.: Market Size, By Application, 2015–2022 (USD Million)
Table 44 France: Bone Growth Stimulator Market Size, By Product, 2015–2022 (USD Million)
Table 45 France: Market Size, By Application, 2015–2022 (USD Million)
Table 46 Rest of Europe: Market Size, By Product, 2015–2022 (USD Million)
Table 47 Rest of Europe: Market Size, By Application, 2015–2022 (USD Million)
Table 48 Asia-Pacific: Bone Growth Stimulator Market Size, By Country, 2015–2022 (USD Million)
Table 49 Asia-Pacific: Market Size, By Product, 2015–2022 (USD Million)
Table 50 Asia-Pacific: Bone Growth Stimulation Devices Market Size, By Type, 2015–2022 (USD Million)
Table 51 Asia-Pacific: External Bone Growth Stimulator Market Size, By Type, 2015–2022 (USD Million)
Table 52 Asia-Pacific: Market Size, By End User, 2015–2022 (USD Million)
Table 53 Asia-Pacific: Market Size, By Application, 2015–2022 (USD Million)
Table 54 Japan: Bone Growth Stimulator Market Size, By Product, 2015–2022 (USD Million)
Table 55 Japan: Market Size, By Application, 2015–2022 (USD Million)
Table 56 China: Bone Growth Stimulator Market Size, By Product, 2015–2022 (USD Million)
Table 57 China: Market Size, By Application, 2015–2022 (USD Million)
Table 58 India: Bone Growth Stimulator Market Size, By Product, 2015–2022 (USD Million)
Table 59 India: Market Size, By Application, 2015–2022 (USD Million)
Table 60 RoAPAC: Market Size, By Product, 2015–2022 (USD Million)
Table 61 RoAPAC: Market Size, By Application, 2015–2022 (USD Million)
Table 62 RoW: Bone Growth Stimulator Market Size, By Product, 2015–2022 (USD Million)
Table 63 RoW: Bone Growth Stimulation Devices Market Size, By Type, 2015–2022 (USD Million)
Table 64 RoW: External Bone Growth Stimulator Market Size, By Type, 2015–2022 (USD Million)
Table 65 RoW: Market Size, By End User, 2015–2022 (USD Million)
Table 66 RoW: Market Size, By Application, 2015–2022 (USD Million)

List of Figures (67 Figures)

Figure 1 Global Bone Growth Stimulators Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Research Methodology: Top-Down Approach
Figure 5 Research Methodology: Bottom-Up Approach
Figure 6 Geriatric Population, By Region, 2015 vs 2030 vs 2050 (Million)
Figure 7 Healthcare Expenditure Across Major Countries, 2000–2014
Figure 8 Healthcare Expenditure Across Major Regions, 2000–2014
Figure 9 Number of Road Accidents Worldwide, 2010 vs 2014
Figure 10 Data Triangulation Methodology
Figure 11 Bone Growth Stimulators Market Size, By Product (2017 vs 2022)
Figure 12 Bone Growth Stimulation Devices Market Size, By Type (2017 vs 2022)
Figure 13 Bone Growth Stimulator Market Share, By End User (2017 vs 2022)
Figure 14 Market Size, By Application (2017 vs 2022)
Figure 15 Market Share, By Region (2016)
Figure 16 Increasing Target Patient Population—Primary Growth Driver of the Market
Figure 17 U.S. Commanded the Largest Share of the Bone Growth Stimulator Market in 2017
Figure 18 Spinal Fusion Surgeries Segment Will Continue to Dominate the Bone Growth Stimulator Market in 2022
Figure 19 Hospitals & Clinics Segment to Account for the Largest Share of the Global Bone Growth Stimulator Market in 2017
Figure 20 India and China are Lucrative Markets for Manufacturers of Bone Growth Stimulators
Figure 21 Supply Chain Analysis: Bone Growth Stimulators Industry (2016)
Figure 22 Market: Porter’s Five Forces Analysis (2016)
Figure 23 PRP, the Fastest-Growing Segment of the Global Market
Figure 24 Spinal Fusion Surgeries, the Fastest-Growing Application Segment of the Global Market
Figure 25 Hospitals & Clinics to Be the Fastest-Growing End-User Segment in the Global Bone Growth Stimulator Market
Figure 26 Asia-Pacific to Offer High Growth Potential in the Global Bone Growth Stimulators Market
Figure 27 North America: Market Snapshot
Figure 28 Europe: Market Snapshot
Figure 29 Asia-Pacific: Market Snapshot
Figure 30 Dive Chart
Figure 31 Orthofix International N.V.: Company Snapshot (2015)
Figure 32 Orthofix International N.V.: Product Offering Scorecard
Figure 33 Orthofix International N.V.: Business Strategy Scorecard
Figure 34 DJO Finance LLC: Company Snapshot (2015)
Figure 35 DJO Finance LLC: Product Offering Scorecard
Figure 36 DJO Finance LLC : Business Strategy Scorecard
Figure 37 Zimmer Biomet Holdings, Inc.: Company Snapshot (2015)
Figure 38 Zimmer Biomet Holdings, Inc.: Product Offering Scorecard
Figure 39 Zimmer Biomet Holdings, Inc.: Business Strategy Scorecard
Figure 40 Bioventus LLC: Product Offering Scorecard
Figure 41 Bioventus LLC: Business Strategy Scorecard
Figure 42 Medtronic PLC: Company Snapshot (2016)
Figure 43 Medtronic PLC: Product Offering Scorecard
Figure 44 Medtronic PLC: Business Strategy Scorecard
Figure 45 Stryker Corporation: Company Snapshot (2015)
Figure 46 Stryker Corporation: Product Offering Scorecard
Figure 47 Stryker Corporation: Business Strategy Scorecard
Figure 48 Johnson & Johnson: Company Snapshot (2016)
Figure 49 Johnson & Johnson: Product Offering Scorecard
Figure 50 Johnson & Johnson: Business Strategy Scorecard
Figure 51 Arthrex, Inc.: Product Offering Scorecard
Figure 52 Arthrex, Inc.: Business Strategy Scorecard
Figure 53 Isto Biologics: Product Offering Scorecard
Figure 54 Isto Biologics: Business Strategy Scorecard
Figure 55 Terumo Corporation: Company Snapshot (2015)
Figure 56 Terumo Corporation: Product Offering Scorecard
Figure 57 Terumo Corporation: Business Strategy Scorecard
Figure 58 Ossatec Benelux Ltd.: Product Offering Scorecard
Figure 59 Ossatec Benelux Ltd.: Business Strategy Scorecard
Figure 60 Ember Therapeutics, Inc.: Product Offering Scorecard
Figure 61 Ember Therapeutics, Inc.: Business Strategy Scorecard
Figure 62 Regen Lab SA: Product Offering Scorecard
Figure 63 Regen Lab SA: Business Strategy Scorecard
Figure 64 Altis Biologics (Pty) Ltd.: Product Offering Scorecard
Figure 65 Altis Biologics (Pty) Ltd.: Business Strategy Scorecard
Figure 66 ITO Co., Ltd: Product Offering Scorecard
Figure 67 ITO Co., Ltd: Business Strategy Scorecard

The global bone growth stimulator market is expected to reach a value of USD 1.41 Billion by 2022, growing at a CAGR of 5.4% during the forecast period.

The growing inclination of patients towards non-invasive and minimally invasive surgical treatments; increasing geriatric, diabetic, and obese population; and procedural and cost benefits offered by bone stimulation devices in bone fracture treatments are some key factors propelling the growth of this market. However, legal issues against market players and side effects associated with BMP-based orthopedic treatment are the key challenges faced by the majority of the bone growth stimulators manufacturers.

On the basis of product, the global market is segmented into bone growth stimulation devices, bone morphogenetic protein (BMPs), and platelet-rich plasma (PRP). The PRP segment is expected to grow at the highest CAGR during the forecast period primarily owing to the increasing use of PRP in sports injuries and the expansion of its applications (due to a growing number of clinical trials).

On the basis of application, the global bone growth stimulator market is segmented into spinal fusion surgeries, delayed union and nonunion bone fractures, dental and maxillofacial surgeries, and other applications. The spinal fusion surgeries segment is expected to grow at the highest CAGR during 2017 to 2022, owing to the growing geriatric population, rising number of spine procedures (and rate of spinal fusion failure), established safety and efficacy of stimulators in fusion surgery, and increasing use of bone growth stimulation products.

On the basis of end user, the global bone growth stimulator market is segmented into hospitals & clinics, home care, and academic & research institutes and CROs. In 2016, the hospitals & clinics segment accounted for the largest of the market. The advantages of bone growth stimulation products over their counterparts are the key factor driving their adoption in this end-user segment.

On the basis of region, the market is classified into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, the global bone growth stimulator market was dominated by North America, mainly due to the growing elderly population, significant presence of market players, and increasing incidence of arthritis and sports injuries.

Bone Growth Stimulators Market

Orthofix International N.V. (U.S.), Medtronic plc (Ireland), Zimmer Biomet Holdings, Inc. (U.S.), DJO Finance LLC (U.S.), Bioventus LLC (U.S.), Stryker Corporation (U.S.), DePuy Synthes (U.S.), Arthrex, Inc. (U.S.), Isto Biologics (U.S.), and Harvest Technologies Corporation (U.S.) are some of the players operating the bone growth stimulator market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services